Your browser doesn't support javascript.
loading
ITSN1: a novel candidate gene involved in autosomal dominant neurodevelopmental disorder spectrum.
Bruel, Ange-Line; Vitobello, Antonio; Thiffault, Isabelle; Manwaring, Linda; Willing, Marcia; Agrawal, Pankaj B; Bayat, Allan; Kitzler, Thomas M; Brownstein, Catherine A; Genetti, Casie A; Gonzalez-Heydrich, Joseph; Jayakar, Parul; Zyskind, Jacob W; Zhu, Zehua; Vachet, Clemence; Wilson, Gena R; Pruniski, Brianna; Goyette, Anne-Marie; Duffourd, Yannis; Thauvin-Robinet, Christel; Philippe, Christophe; Faivre, Laurence.
Afiliação
  • Bruel AL; UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France. ange-line.bruel@u-bourgogne.fr.
  • Vitobello A; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France. ange-line.bruel@u-bourgogne.fr.
  • Thiffault I; UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.
  • Manwaring L; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
  • Willing M; Center for Pediatric Genomic Medicine, Children's Mercy Hospital, Kansas City, MO, USA.
  • Agrawal PB; Department of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Bayat A; Department of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Kitzler TM; Divisions of Newborn Medicine, Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA, USA.
  • Brownstein CA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Genetti CA; Department of Genetics and Precision Medicine, Danish Epilepsy Centre, Dianalund, Denmark.
  • Gonzalez-Heydrich J; Research Institute, McGill University Health Centre, Montreal, QC, Canada.
  • Jayakar P; Division of Medical Genetics, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
  • Zyskind JW; Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Zhu Z; Divisions of Newborn Medicine, Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA, USA.
  • Vachet C; Divisions of Newborn Medicine, Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA, USA.
  • Wilson GR; Department of Psychiatry, Boston Children's Hospital, Manton Center for Orphan Disease Research, Division of Genetics and Genomics, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Pruniski B; Division of Genetics and Metabolism, Nicklaus Children's Hospital, Miami, FL, USA.
  • Goyette AM; GeneDX, Gaitherburg, MD, USA.
  • Duffourd Y; GeneDX, Gaitherburg, MD, USA.
  • Thauvin-Robinet C; Service de néphrologie pédiatrique, Centre Hospitalier Régional Universitaire Besançon, Besançon, France.
  • Philippe C; Division of Genetics and Metabolism, Phoenix Children's Medical Group, Phoenix, AZ, USA.
  • Faivre L; Division of Genetics and Metabolism, Phoenix Children's Medical Group, Phoenix, AZ, USA.
Eur J Hum Genet ; 30(1): 111-116, 2022 01.
Article em En | MEDLINE | ID: mdl-34707297
ABSTRACT
ITSN1 plays an important role in brain development. Recent studies in large cohorts of subjects with neurodevelopmental disorders have identified de novo variants in ITSN1 gene thereby suggesting that this gene is involved in the development of such disorders. The aim of this study is to provide further proof of such a link. We performed trio exome sequencing in a patient presenting autism, intellectual disability, and severe behavioral difficulties. Additional affected patients with a neurodevelopmental disorder harboring a heterozygous variant in ITSN1 (NM_003024.2) were collected through a worldwide collaboration. All patients underwent detailed phenotypic and genetic assessment and data was collected and shared by healthcare givers. We identified ten novel patients from eight families with heterozygous truncating or missense variants in ITSN1 gene. In addition, four previously published patients from large meta-analysis studies were included. In total, 7/14 patients presented a de novo variant in ITSN1. All patients showed neurodevelopmental disorders from autism spectrum disorders (90%), intellectual disability (86%), and epilepsy (30%). We demonstrated that truncating variants are in the first half of ITSN1 whereas missense variants are clustered in C-terminal region. We suggest ITSN1 gene is involved in development of an autism spectrum disorder with variable additional neurodevelopmental deficiency, thus confirming the hypothesis that ITSN1 is important for brain development.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Deficiências do Desenvolvimento / Proteínas Adaptadoras de Transporte Vesicular / Epilepsia / Deficiência Intelectual Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Deficiências do Desenvolvimento / Proteínas Adaptadoras de Transporte Vesicular / Epilepsia / Deficiência Intelectual Idioma: En Ano de publicação: 2022 Tipo de documento: Article